prazosin has been researched along with Elevated Cholesterol in 17 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of enalapril and terazosin on serum lipid profile was investigated in 36 patients with primary hypertension and hypercholesterolemia (total cholesterol 5." | 7.68 | [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia]. ( Hańczycowa, H; Jordanek, P; Jurga, M; Ponikowski, P; Rotter, A; Sebzda, T; Spring, A, 1993) |
"In an open multicenter prospective study, the effects of short-term (4 weeks, n = 101) and long-term (6 months, n = 38) terazosin treatment on blood pressure, serum lipids and safety in the patients with mild to moderate essential hypertension were observed." | 5.09 | Effect of terazosin on blood pressure and serum lipids. ( Cheng, L; Gong, P; Lu, Z; Tang, J; Zeng, F; Zhang, J, 1999) |
"The effect of enalapril and terazosin on serum lipid profile was investigated in 36 patients with primary hypertension and hypercholesterolemia (total cholesterol 5." | 3.68 | [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia]. ( Hańczycowa, H; Jordanek, P; Jurga, M; Ponikowski, P; Rotter, A; Sebzda, T; Spring, A, 1993) |
"Prazosin (Minipress) monotherapy was given to 152 patients with essential hypertension for one year in a multi-center study involving 13 hospitals and university clinics." | 3.68 | [The anti-lipidemic effect of Minipress]. ( Dudás, M; Farsang, C; Földes, I; Iványi, J; Pados, G, 1990) |
"The effect of doxazosin administration on hemodynamics, hemostasis, and serum lipid and lipoprotein levels was investigated in cynomolgus monkeys (Macaca fascicularis) with diet-induced hypercholesterolemia." | 3.67 | Serum lipids, lipoproteins, hemodynamics, and hemostasis in doxazosin-treated monkeys. ( Karge, WH; Kowala, MC; Nicolosi, RJ; Weiner, EJ, 1989) |
"Because coronary heart disease is known to have many causes, primary preventive therapy must logically go beyond the relatively simple goal of lowering blood pressure." | 2.66 | Effects of oral antihypertensive agents on blood lipid levels. ( Leren, P, 1986) |
"Prazosin treatment significantly decreased mean arterial pressure in normal and hypercholesterolemic monkeys." | 1.28 | Effects of prazosin on hemodynamics, hemostasis, and serum lipid and lipoprotein levels in normal and hypercholesterolemic monkeys. ( Graham, RM; Karge, WH; Kowala, MC; Nicolosi, RJ; Weiner, EJ, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (47.06) | 18.7374 |
1990's | 7 (41.18) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bur, A | 1 |
Woisetschläger, C | 1 |
Herkner, H | 1 |
Derhaschnig, U | 1 |
Quehenberger, P | 1 |
Hirschl, MM | 1 |
Gong, P | 1 |
Tang, J | 1 |
Cheng, L | 1 |
Lu, Z | 1 |
Zhang, J | 1 |
Zeng, F | 1 |
Jatwa, R | 1 |
Kar, A | 1 |
Ponikowski, P | 1 |
Hańczycowa, H | 1 |
Sebzda, T | 1 |
Jurga, M | 1 |
Spring, A | 1 |
Rotter, A | 1 |
Jordanek, P | 1 |
Makaritsis, KP | 1 |
Gavras, H | 1 |
Du, Y | 1 |
Chobanian, AV | 1 |
Brecher, P | 1 |
Foxall, TL | 1 |
Shwaery, GT | 1 |
Stucchi, AF | 1 |
Nicolosi, RJ | 3 |
Wong, SS | 1 |
Jansson, JH | 1 |
Johansson, B | 1 |
Boman, K | 1 |
Nilsson, TK | 1 |
Pool, JL | 1 |
Lenz, ML | 1 |
Taylor, AA | 1 |
Pados, G | 1 |
Iványi, J | 1 |
Földes, I | 1 |
Dudás, M | 1 |
Farsang, C | 1 |
Karge, WH | 2 |
Kowala, MC | 2 |
Weiner, EJ | 2 |
Jansen, H | 1 |
Lammers, R | 1 |
Baggen, MG | 1 |
Penders, JM | 1 |
Birkenhäger, JC | 1 |
Leren, P | 1 |
Swindell, AC | 1 |
Valentine, JJ | 1 |
Seki, K | 1 |
Watanabe, T | 1 |
Suga, T | 1 |
Leren, TP | 1 |
Berg, K | 1 |
Graham, RM | 1 |
Leon, AS | 1 |
Hunninghake, DB | 1 |
Belcher, J | 1 |
Stoulil, J | 1 |
5 trials available for prazosin and Elevated Cholesterol
Article | Year |
---|---|
[Effects of terazosine and atenolol on serum lipids in essential hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Ate | 2002 |
Effect of terazosin on blood pressure and serum lipids.
Topics: Antihypertensive Agents; Blood Pressure; Essential Hypertension; Humans; Hypercholesterolemia; Hyper | 1999 |
Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Double-Blind Method; Doxazosi | 1991 |
Effects of oral antihypertensive agents on blood lipid levels.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Cl | 1986 |
Comparative effects of prazosin and propranolol on blood lipid profiles in hypertensive, hypercholesterolemic patients. Preliminary results.
Topics: Adult; Aged; Apoproteins; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholester | 1989 |
12 other studies available for prazosin and Elevated Cholesterol
Article | Year |
---|---|
Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Glucose; Cholesterol, Dietary; Disease Models, Animal; | 2006 |
[Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia].
Topics: Adrenergic alpha-Antagonists; Adult; Enalapril; Female; Humans; Hypercholesterolemia; Hypertension; | 1993 |
Alpha1-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice.
Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Ap | 1998 |
Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
Topics: Adrenergic alpha-Antagonists; Animals; Aortic Diseases; Arteriosclerosis; Cricetinae; Dose-Response | 1992 |
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
Topics: Adrenergic alpha-Antagonists; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dox | 1990 |
[The anti-lipidemic effect of Minipress].
Topics: Coronary Disease; Drug Evaluation; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Hypo | 1990 |
Serum lipids, lipoproteins, hemodynamics, and hemostasis in doxazosin-treated monkeys.
Topics: Adrenergic alpha-Antagonists; Animals; Apolipoproteins B; Disease Models, Animal; Doxazosin; Hemodyn | 1989 |
Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.
Topics: Acetates; Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxa | 1989 |
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Dise | 1987 |
Influence of the new antihypertensive drug, SM-2470 (a quinazoline derivative), on cholesterol metabolism in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Hypercholesterolemia; Intestinal Absorption; Int | 1987 |
Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin.
Topics: Adrenergic alpha-Antagonists; Animals; Chinchilla; Cholesterol; Doxazosin; Drug Evaluation, Preclini | 1988 |
Effects of prazosin on hemodynamics, hemostasis, and serum lipid and lipoprotein levels in normal and hypercholesterolemic monkeys.
Topics: Animals; Apoproteins; Blood Coagulation; Blood Pressure; Cholesterol; Heart Rate; Hemodynamics; Hemo | 1989 |